"RAOC is a retina group of renowned board-certified Ophthalmologists who are fellowship-trained in vitreoretinal surgery and specialize in diseases of the retina, macula and vitreous. Our doctors have a remarkable history that combines teaching at prestigious academic institutions in concert with excellence in patient care in the private practice setting. Our physicians have received numerous honors and awards including “Best Doctors of America”, “Top Doctors in Orange County”, “Teacher of the Year”, and "Physician of Excellence" from the Orange County Medical Association."

During the past decade, Retina Associates of Orange County conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Associates of Orange County" #1 sponsor was "Kodiak Sciences Inc" with 3 trials, followed by "Allergan" with 1 trials sponsored, "Lpath, Inc." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "ThromboGenics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Retina Associates of Orange County" are "Diabetic Macular Edema" (1 trials), "Exudative Age-related Macular Degeneration" (1 trials), "Macular Degeneration" (1 trials), "Macular Edema, Diabetic" (1 trials) and "Symptomatic Vitreomacular Adhesion" (1 trials). Many other conditions were trialed in "Retina Associates of Orange County" in a lesser frequency.

Most popular intervention types in "Retina Associates of Orange County" are "Drug" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "KSI-301" (3 trials), "Ranibizumab" (2 trials) and "0.5 mg Lucentis or 1.25 mg Avastin or 2 mg Eylea" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Associates of Orange County" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Retina Associates of Orange County". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Retina Associates of Orange County, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Associates of Orange County, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".